Economy

Israel blocks Arab foreign ministers from meeting in West Bank

Unlock the White House Watch newsletter for free Are you interested in staying informed about what Trump’s second term means for Washington, business, and the world? Look no further than

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.

Lasted Economy

Boston Scientific (BSX) Fell Amid Rising Competition

Baron Funds, a renowned investment management company, recently published its third-quarter 2025 investor letter for the "Baron Health Care Fund."

The best cash-back credit cards for 2025

Cash-back credit cards have become increasingly popular among consumers looking to earn rewards on their everyday spending. These cards offer

5 common traffic violations and how they affect your car insurance

A ticket, at-fault accident, or driving-related conviction can have a significant impact on your driving record and ultimately raise your

Novo Nordisk trims outlook as obesity drug maker loses ground to Eli Lilly

Novo Nordisk, a leading pharmaceutical company known for its Wegovy obesity drug, has recently faced challenges in the market. The

Amgen profit beats estimates, weight-loss data due by year-end

Amgen, a leading biotech company based in California, exceeded expectations with its quarterly financial results and raised its full-year outlook.

The London Company Income Equity Portfolio Chose to Exit Fidelity National Information Services (FIS) in Q3

The London Company, an investment management firm, recently released their third-quarter 2025 investor letter outlining the performance of their Income

Why Liberalism – Econlib

In the early days of my teaching career, I received a nugget of wisdom from David Henderson: to be transparent

Novo Nordisk and Pfizer’s bidding war for Metsera escalates despite legal threats

Novo Nordisk and Pfizer are currently engaged in a fierce bidding war over the acquisition of obesity biotech company Metsera.